FindTrial
Sign In

COMPARISON OF TWO ANAESTHETIC TECHNIQUES CHILDREN UNDERGOING EAR SURGERY

COMPARISON OF CONVENTIONAL GENERAL ANAESTHESIA WITH TOTAL INTRAVENOUS ANAESTHESIA IN CHILDREN UNDERGOING COCHLEAR IMPLANT SURGERY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012610
Enrollment
50
Registered
2018-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- CHILDREN WITH HEARING DISABILITY UNDERGOING COCHLEAR IMPLANT SURGERY UNDER GENERAL ANAESTHESIA Health Condition 2: H838- Other specified diseases of innerear

Interventions

Intervention1: TOTAL INTRAVENOUS ANAESTHESIA USING PROPOFOL AND FENTANYL: CHILDREN IN THIS GROUP WILL RECEIVE GENERAL ANAESTHESIA BY TOTAL INTRAVENOUS ANAESTHESIA (I.V) WITH PROPOFOL 13mg/kg/hr REDUCE

Sponsors

ALL INDIA INSTITUTE OF MEDICAL SCIENCES NEW DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CHILDREN OF AGE GROUP 3-16 YEARS POSTED FOR COCHLEAR IMPLANT SURGERY

Exclusion criteria

Exclusion criteria: SEVERE INTELLECTUAL DISABILITY. ASA PHYSICAL STATUS 3 and 4.

Design outcomes

Primary

MeasureTime frame
POST OPERATIVE NAUSEA AND VOMITINGTimepoint: 1.INTRA OPERATIVE PERIOD EVERY I5 MINUTES 2.POST OPERATIVE 5,30 MIN,1,2,6,12,24 HOURS—

Secondary

MeasureTime frame
1.The intra operative haemodynamic changes. 2.Any significant intra operative events 3.Immediate post operative recovery profile â?¢Time of recovery from anaesthesia â?¢Quality of recovery 4.Analgesic requirement for first 24 hours. Timepoint: 1.INTRA OPERATIVE PERIOD EVERY I5 MINUTES 2.POST OPERATIVE 5,30 MIN,1,2,6,12,24 HOURS—

Countries

India

Contacts

Public ContactKANIL RANJITH KUMAR

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI

mayadehran@yahoo.com9868397807

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026